The Australian government signs an agreement with Merck Sharp & Dohme to buy 300,000 courses of the antiviral drug molnupiravir, pending regulator clearance, which would be the first pill to treat COVID-19 patients. (9 News) COVID-19 pandemic in Australia, COVID-19 drug developmentCOVID-19 pandemic in OceaniaCOVID-19 pandemic link embed save